Vertex Pharma (VRTX) Tops Q3 EPS by 23c, provides guidance

November 3, 2025 4:06 PM EST
Get Alerts VRTX Hot Sheet
Price: $516.44 --0%

Financial Fact:
Royalty expenses: 855K

Today's EPS Names:
PARA, RNTX, SURG, More
Join SI Premium – FREE

Vertex Pharma (NASDAQ: VRTX) reported Q3 EPS of $4.80, $0.23 better than the analyst estimate of $4.57. Revenue for the quarter came in at $3.08 billion versus the consensus estimate of $3.05 billion.

GUIDANCE:

Vertex Pharma sees FY2025 revenue of $11.9-12 billion, versus the consensus of $12.002 billion.

For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK